A majority of educators say their districts’ career and technical education offerings are increasing, driven in large part by growing student demand. That’s according to an EdWeek Research Center ...
Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...
This story mentions suicide. Mental health resources can be found at the bottom of this story. The death of Dallas Cowboys defensive end Marshawn Kneeland from an apparent self-inflicted gunshot wound ...
Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...
The neurologic disease called chronic traumatic encephalopathy or CTE has most often been found in people who experienced repeated blows to the head while playing contact sports and there’s now ...
Recursion Pharmaceuticals remains a high-cash-burn, premium-valued biotech with unproven clinical success despite a recent 47% rally. RXRX's next 18 months are catalyst-rich, but key pipeline assets ...
In Hans Christian Andersen's folktale, The Emperor's New Clothes, when a child cries out that the emperor is naked, he isn't revealing a secret. Everyone already knows it. What changes in that instant ...
The gunman who unleashed chaos in a Midtown Manhattan skyscraper this summer is a stark reminder of how little we know about a devastating brain disease typically associated with NFL players — which ...
Late last month, the New York City medical examiner confirmed the man who shot and killed four people at a Manhattan office tower had the degenerative brain disease Chronic Traumatic Encephalopathy, ...
Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...
A groundbreaking new study is underway that could help football players and other athletes who may be more at risk for concussions. University of California, San Francisco researchers are studying the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results